| By Jan Paschal Posted May 7, 2026 Mobia Medical (MOBI) priced its IPO at $15.00 – the mid-point of its $14.00-to-$16.00 price range – to raise $150 million on Thursday night, May 7, 2026. The Texas medical device company’s stock is expected to start trading tomorrow – Friday, May 8, 2026 – on the NASDAQ. BofA Securities, J.P. Morgan and Goldman Sachs led the joint book-running team, which included BTIG and Wolfe Nomura Alliance. Mobia Medical (MOBI), based in Austin, Texas, is a commercial-stage MedTech company that makes an FDA-approved implantable medical device – the ViviStimi System – to stimulate the vagus nerve and help stroke victims regain use of their upper extremities – their shoulders, arms, forearms and hands, according to the prospectus. The company launched its device in 2023. Mobia Medical had an accumulated deficit of about $157.8 million as of Dec. 31, 2025. The company is not profitable. Mobia Medical reported a net loss of $46.5 million on revenue of $32 million for the year that ended Dec. 31, 2025, according to financial statements in the prospectus. (For more information about this company, please check the IPO Calendar and the individual IPO Profile found on the IPOScoop.com website.) Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message. Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions. |
